Therapeutic Goods Administration

Jessica Collins

On behalf of Senator Antic, I move:

That there be laid on the table by the Minister representing the Minister for Health and Aged Care, by no later than 9.30 am on Monday, 20 April 2026:

(a) all current and historical terms of reference, workplans, designation agreements and any amendments or renewals for the Therapeutic Goods Administration's (TGA) World Health Organization (WHO) collaborating centres for drug quality assurance and for the quality assurance of vaccines and other biologicals;

(b) all correspondence, emails, meeting minutes, reports and briefings between the TGA (or Department of Health) and the WHO relating to these collaborating centre designations, including annual progress reports submitted to WHO, invitations for input on WHO standards/guidance and any discussions on regulatory alignment or influence since 2015;

(c) any documents, including internal advice and memos, assessing the implications of these WHO collaborating centre affiliations for TGA's independence, decision-making on therapeutic goods approvals or Australian sovereignty in medicines/vaccines regulation; and

(d) a list of any WHO-requested activities, technical support provided or changes to TGA processes resulting from these affiliations.

Slade Brockman

The question is that general business notice of motion No. 434 be agreed to.